Complex patterns of ADAM12 mRNA and protein splice variants in the human placenta

Annals of Anatomy

Volumn 193, Issue 2, 2011, Pages 142-148

  Kokozidou, M ^a,b   Drewlo, S ^c   Bartz, C ^b   Raven, G ^d   Brandenburg, L O ^a   Wruck, C J ^a   Pufe, T ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c MOUNT SINAI HOSPITAL   (Canada)

^d Casa Maastricht   (Netherlands)

Author keywords

ADAM12; ADAM12 L; ADAM12 S; Fusion; Human placenta; Trophoblast histopathology

Indexed keywords

ADAM PROTEIN; ADAM12 L PROTEIN; ADAM12 PROTEIN; ADAM12 S PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL STRAIN HEK293; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTROPHOBLAST; EMBRYO; FEMALE; FIRST TRIMESTER PREGNANCY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LEUKOCYTE; MACROPHAGE; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PLACENTA; PROTEIN LOCALIZATION; RNA SPLICING; SYNCYTIUM; THIRD TRIMESTER PREGNANCY;

ADAM PROTEINS; FEMALE; HUMANS; MEMBRANE PROTEINS; PLACENTA; PREGNANCY; PROTEIN ISOFORMS; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 79952105535     PISSN: 09409602     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aanat.2010.12.002     Document Type: Article

References (33)

1. Albrechtsen R., Stautz D., Sanjay A., Kveiborg M., Wewer U.M. Extracellular engagement of ADAM12 induces clusters of invadopodia ectodomain shedding activity. Experimental Cell Research 2011, 317:195-209.
2. Asakura M., Kitakaze M., Takashima S., Liao Y., Ishikura F., Yoshinaka T., Ohmoto H., Node K., Yoshino K., Ishiguro H., Asanuma H., Sanada S., Matsumura Y., Takeda H., Beppu S., Tada M., Hori M., Higashiyama S. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nature Medicine 2002, 8:35-40.
3. Blond J.L., Beseme F., Duret L., Bouton O., Bedin F., Perron H., Mandrand B., Mallet F. Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. Journal of Virology 1999, 73:1175-1185.
4. Blond J.L., Lavillette D., Cheynet V., Bouton O., Oriol G., Chapel-Fernandes S., Mandrand B., Mallet F., Cosset F.L. An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. Journal of Virology 2000, 74:3321-3329.
5. Borges M., Bose P., Frank H.G., Kaufmann P., Potgens A.J.G. A two-colour fluorescence assay for the measurement of syncytial fusion between trophoblast-derived cell lines. Placenta 2003, 24:959-964.
6. Carl-McGrath S., Lendeckel U., Ebert M., Roessner A., Rocken C. The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer. International Journal of Oncology 2005, 26:17-24.
7. Church H.J., Aplin J.D. BeWo choriocarcinoma cells produce laminin 10. Biochemical Journal 1998, 332:491-498.
8. Cowans N.J., Spencer K. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system. Prenatal Diagnosis 2007, 27:264-271.
9. Drewlo S., Leyting S., Kokozidou M., Mallet F., Potgens A.J. C-Terminal truncations of syncytin-1 (ERVWE1 envelope) that increase its fusogenicity. Biological Chemistry 2006, 387:1113-1120.
10. van den Eijnde S.M., van den Hoff M.J., Reutelingsperger C.P., van Heerde W.L., Henfling M.E., Vermeij-Keers C., Schutte B., Borgers M., Ramaekers F.C. Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation. Journal of Cell Science 2001, 114:3631-3642.
11. Fedak P.W.M., Moravec C.S., McCarthy P.M., Altamentova S.M., Wong A.P., Skrtic M., Verma S., Weisel R.D., Li R.K. Altered expression of disintegrin metalloproteinases and their inhibitor in human dilated cardiomyopathy. Circulation 2006, 113:238-245.
12. Frohlich C., Albrechtsen R., Dyrskjot L., Rudkjaer L., Orntoft T.F., Wewer U.M. Molecular profiling of ADAM12 in human bladder cancer. Clinical Cancer Research 2006, 12:7359-7368.
13. Gilpin B.J., Loechel F., Mattei M.G., Engvall E., Albrechtsen R., Wewer U.M. A novel, secreted form of human ADAM 12 (meltrin alpha) provokes myogenesis in vivo. Journal of Biological Chemistry 1998, 273:157-166.
14. Huppertz B., Frank H.G., Kingdom J.C., Reister F., Kaufmann P. Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta. Histochemistry and Cell Biology 1998, 110:495-508.
15. Huppertz B., Bartz C., Kokozidou M. Trophoblast fusion: fusogenic proteins, syncytins and ADAMs, and other prerequisites for syncytial fusion. Micron 2006, 37:509-517.
16. Iba K., Albrechtsen R., Gilpin B.J., Loechel F., Wewer U.M. Cysteine-rich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion. American Journal of Pathology 1999, 154:1489-1501.
17. Kawaguchi N., Sundberg C., Kveiborg M., Moghadaszadeh B., Asmar M., Dietrich N., Thodeti C.K., Nielsen F.C., Möller P., Mercurio A.M., Albrechtsen R., Wewer U.M. ADAM12 induces actin cytoskeleton and extracellular matrix reorganization during early adipocyte differentiation by regulating beta1 integrin function. Journal of Cell Science 2003, 116:3893-3904.
18. Kveiborg M., Albrechtsen R., Rudkjaer L., Wen G.M., Damgaard-Pedersen K., Wewer U.M. ADAM12-S stimulates bone growth in transgenic mice by modulating chondrocyte proliferation and maturation. Journal of Bone and Mineral Research 2006, 21:1288-1296.
19. Laigaard J., Sorensen T., Frohlich C., Fröhlich C., Pedersen B.N., Christiansen M., Schiøtt K., Uldbjerg N., Albrechtsen R., Clausen H.V., Ottesen B., Wewer U.M. ADAM12: a novel first-trimester maternal serum marker for Down syndrome. Prenatal Diagnosis 2003, 23:1086-1091.
20. Laigaard J., Sorensen T., Placing S., Holck P., Fröhlich C., Wøjdemann K.R., Sundberg K., Shalmi A.C., Tabor A., Nørgaard-Pedersen B., Ottesen B., Christiansen M., Wewer U.M. Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia. Obstetrics and Gynecology 2005, 106:144-149.
21. Mori S., Tanaka M., Nanba D., Nishiwaki E., Ishiguro H., Higashiyama S., Matsuura N. PACSIN3 binds ADAM12/meltrin alpha and up-regulates ectodomain shedding of heparin-binding epidermal growth factor-like growth factor. Journal of Biological Chemistry 2003, 278:46029-46034.
22. Niimi T., Hayashi Y., Sekiguchi K., Kitagawa Y. The Sp family of transcription factors regulates the human laminin alpha1 gene in JAR choriocarcinoma cells. Biochimica et Biophysica Acta 2006, 1759:573-579.
23. le Pabic H., Bonnier D., Wewer U.M., Coutand A., Musso O., Baffet G., Clément B., Théret N. ADAM12 in human liver cancers: TGF-beta-regulated expression in stellate cells is associated with matrix remodeling. Hepatology 2003, 37:1056-1066.
24. Potgens A.J., Drewlo S., Kokozidou M., Kaufmann P. Syncytin: the major regulator of trophoblast fusion? Recent developments and hypotheses on its action. Human Reproduction Update 2004, 10:487-496.
25. Prenzel N., Zwick E., Daub H., Leserer M., Abraham R., Wallasch C., Ullrich A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 1999, 402:884-888.
26. Richart R. Studies of placental morphogenesis: I. Radioautographic studies of human placenta utilizing tritiated thymidine. Proceedings of the Society for Experimental Biology and Medicine 1961, 106:829-831.
27. Roy R., Wewer U.M., Zurakowski D., Pories S.E., Moses M.A. ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage. Journal of Biological Chemistry 2004, 279:51323-51330.
28. Spencer K., Cowans N.J. ADAM12 as a marker of trisomy 18 in the first and second trimester of pregnancy. Journal of Maternal-Fetal and Neonatal Medicine 2007, 20:645-650.
29. Suzuki A., Kadota N., Hara T., Nakagami Y., Izumi T., Takenawa T., Sabe H., Endo T. Meltrin alpha cytoplasmic domain interacts with SH3 domains of Src and Grb2 and is phosphorylated by v-Src. Oncogene 2000, 19:5842-5850.
30. Vignery A. Osteoclasts and giant cells: macrophage-macrophage fusion mechanism. International Journal of Experimental Pathology 2000, 81:291-304.
31. Wewer U.M., Morgelin M., Holck P., Jacobsen J., Lydolph M.C., Johnsen A.H., Kveiborg M., Albrechtsen R. ADAM12 is a four-leafed clover: the excised prodomain remains bound to the mature enzyme. Journal of Biological Chemistry 2006, 281:9418-9422.
32. Yagami-Hiromasa T., Sato T., Kurisaki T., Kamijo K., Nabeshima Y., Fujisawasehara A. A metalloprotease-disintegrin participating in myoblast fusion. Nature 1995, 377:652-656.
33. Zhao Z., Gruszczynska-Biegala J., Cheuvront T., Yi H., von der Mark H., von der Mark K., Kaufman S.J., Zolkiewska A. Interaction of the disintegrin and cysteine-rich domains of ADAM12 with integrin alpha7beta1. Experimental Cell Research 2004, 298:28-37.